InMed Pharmaceuticals, Inc. (INM)
1.36
+0.03
(+2.26%)
USD |
NASDAQ |
Oct 09, 16:00
1.37
+0.01
(+0.74%)
After-Hours: 20:00
InMed Pharmaceuticals Free Cash Flow (Quarterly) : -2.909M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -2.909M |
| March 31, 2026 | -1.759M |
| December 31, 2025 | -2.352M |
| September 30, 2025 | -1.608M |
| June 30, 2025 | -2.322M |
| March 31, 2025 | -1.562M |
| December 31, 2024 | -2.448M |
| September 30, 2024 | -1.827M |
| June 30, 2024 | -0.9628M |
| March 31, 2024 | -1.964M |
| December 31, 2023 | -1.826M |
| September 30, 2023 | -2.174M |
| June 30, 2023 | -0.8963M |
| March 31, 2023 | -1.655M |
| December 31, 2022 | -2.618M |
| September 30, 2022 | -2.256M |
| June 30, 2022 | -3.989M |
| March 31, 2022 | -5.278M |
| December 31, 2021 | -3.568M |
| September 30, 2021 | -2.654M |
| June 30, 2021 | -2.199M |
| March 31, 2021 | -5.598M |
| December 31, 2020 | -1.063M |
| September 30, 2020 | -1.372M |
| June 30, 2020 | -1.242M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.480M |
| December 31, 2019 | -2.069M |
| September 30, 2019 | -2.397M |
| June 30, 2019 | -1.782M |
| March 31, 2019 | -2.081M |
| December 31, 2018 | -1.398M |
| September 30, 2018 | -1.320M |
| June 30, 2018 | -1.005M |
| March 31, 2018 | -0.7639M |
| December 31, 2017 | -0.8126M |
| September 30, 2017 | -1.080M |
| June 30, 2017 | -0.7425M |
| March 31, 2017 | -0.7543M |
| December 31, 2016 | -0.6437M |
| September 30, 2016 | -0.1663M |
| June 30, 2016 | -0.0872M |
| March 31, 2016 | -0.0604M |
| December 31, 2015 | -0.1092M |
| September 30, 2015 | -0.1316M |
| June 30, 2015 | -0.7565M |
| March 31, 2015 | -0.6724M |
| December 31, 2014 | -0.0881M |
| September 30, 2014 | -0.1053M |
| June 30, 2014 | -0.6268M |
| March 31, 2014 | 0.0006M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| NervGen Pharma Corp. | -4.086M |
| Milestone Pharmaceuticals, Inc. | -22.56M |
| Clearmind Medicine, Inc. | -1.859M |
| Lexaria Bioscience Corp. | -1.661M |
| Target Group, Inc. (Canada) | -0.2294M |